Exact Mass: 406.0359

Exact Mass Matches: 406.0359

Found 33 metabolites which its exact mass value is equals to given mass value 406.0359, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Glucoiberverin

(E)-[4-(methylsulfanyl)-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene]amino sulfate

C11H20NO9S3- (406.03)


   
   

spongotine A

spongotine A

C20H15BrN4O (406.0429)


A member of the class of imidazolines that is 4,5-dihydro-1H-imidazole which is substituted by a 1H-indole-3-carbonyl group at position 2 and a 6-bromo-1H-indol-3-yl group at position 4S. It is a bisindole alkaloid isolated from the marine sponge, Spongosorites sp.

   

2-(Benzothiazol-2-ylsulfanyl)-1-phenothiazin-10-yl-ethanone

2-(Benzothiazol-2-ylsulfanyl)-1-phenothiazin-10-yl-ethanone

C21H14N2OS3 (406.0268)


   

6-Debromohamacanthin B

6-Debromohamacanthin B

C20H15BrN4O (406.0429)


   
   

3-(1H-Indole-3-yl)-6-(6-bromo-1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

3-(1H-Indole-3-yl)-6-(6-bromo-1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

C20H15BrN4O (406.0429)


   

cyclographin|Cycographin

cyclographin|Cycographin

C19H15ClO8 (406.0455)


   
   

3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

3-(6-Bromo-1H-indole-3-yl)-6-(1H-indole-3-yl)-1,2,5,6-tetrahydropyrazine-2-one

C20H15BrN4O (406.0429)


   

2-(4-(8-BROMO-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE

2-(4-(8-BROMO-2-OXO-2,3-DIHYDRO-1H-IMIDAZO[4,5-C]QUINOLIN-1-YL)PHENYL)-2-METHYLPROPANENITRILE

C20H15BrN4O (406.0429)


   

Piperazine-N,N-bis(2-hydroxypropanesulphonic acid) disodium salt

Piperazine-N,N-bis(2-hydroxypropanesulphonic acid) disodium salt

C10H20N2Na2O8S2 (406.0456)


   

Fosphenytoin sodium

Fosphenytoin (disodium)

C16H13N2Na2O6P (406.0307)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators

   

9,10-Anthracenedione,1-amino-2-bromo-4-[(4-methylphenyl)amino]-

9,10-Anthracenedione,1-amino-2-bromo-4-[(4-methylphenyl)amino]-

C21H15BrN2O2 (406.0317)


   
   

3-Methylthiopropylglucosinolate

3-Methylthiopropylglucosinolate

C11H20NO9S3- (406.03)


   

3-Thiophenecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

3-Thiophenecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C21H14N2O3S2 (406.0446)


   

2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid

2-[(5Z)-5-(1-methyl-2-oxoindol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanedioic acid

C17H14N2O6S2 (406.0293)


   

N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide

N-[(5-bromo-2-methoxyphenyl)methyl]-4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxamide

C18H19BrN2O2S (406.0351)


   

N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide

N-[(E)-[5-(3-chloro-4-methylphenyl)furan-2-yl]methylideneamino]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide

C17H15ClN4O2S2 (406.0325)


   

2-Thiophenecarboxylic acid 4-[[5-(2-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

2-Thiophenecarboxylic acid 4-[[5-(2-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C21H14N2O3S2 (406.0446)


   

GlcA3S(b1-4)Xyl

GlcA3S(b1-4)Xyl

C11H18O14S (406.0417)


   

GlcA3S(b1-4)b-Xyl

GlcA3S(b1-4)b-Xyl

C11H18O14S (406.0417)


   

[2-Hydroxy-5-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]phenyl] hydrogen sulate

[2-Hydroxy-5-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]phenyl] hydrogen sulate

C18H14O9S (406.0359)


   

glucoiberverin(1-)

glucoiberverin(1-)

C11H20NO9S3 (406.03)


A thia-alkylglucosinolate resulting from the removal of the proton of the hydrogen sulfate group of glucoiberverin.

   

(5r)-3-(6-bromo-1h-indol-3-yl)-5-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one

(5r)-3-(6-bromo-1h-indol-3-yl)-5-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one

C20H15BrN4O (406.0429)


   

methyl 13-chloro-15-formyl-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate

methyl 13-chloro-15-formyl-6,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-5-carboxylate

C19H15ClO8 (406.0455)


   

3-[2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

3-[2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

C20H15BrN4O (406.0429)


   

(5r)-5-(6-bromo-1h-indol-3-yl)-3-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one

(5r)-5-(6-bromo-1h-indol-3-yl)-3-(1h-indol-3-yl)-5,6-dihydro-1h-pyrazin-2-one

C20H15BrN4O (406.0429)


   

3-[(4s)-2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

3-[(4s)-2-(6-bromo-1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

C20H15BrN4O (406.0429)


   

6-bromo-3-[(4s)-2-(1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

6-bromo-3-[(4s)-2-(1h-indole-3-carbonyl)-4,5-dihydro-1h-imidazol-4-yl]-1h-indole

C20H15BrN4O (406.0429)


   

methyl 13-chloro-15-formyl-5,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-6-carboxylate

methyl 13-chloro-15-formyl-5,14-dihydroxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-6-carboxylate

C19H15ClO8 (406.0455)